カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界のH2ブロッカー市場予測2023-2029：ラニチジン/ザンタック、シメチジン、ファモチジン、ナザチジン

【英語タイトル】H2 Blockers Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23JU5600）・商品コード：MMG23JU5600
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年6月
・ページ数：124
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥487,500見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥633,750見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥731,250見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

#VALUE!

This report aims to provide a comprehensive presentation of the global market for H2 Blockers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding H2 Blockers. This report contains market size and forecasts of H2 Blockers in global, including the following market information:Global H2 Blockers Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global H2 Blockers Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five H2 Blockers companies in 2022 (%)
The global H2 Blockers market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Ranitidine/Zantac Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of H2 Blockers include Acic Pharmaceuticals, Actavis Mid Atlantic LLC, Ajanta Pharma, AmerisourceBergen, Amneal Pharmaceuticals, ANDA Repository, Ani Pharmaceuticals, Apotex Inc. (and Apotex Corporation) and Appco Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the H2 Blockers manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global H2 Blockers Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global H2 Blockers Market Segment Percentages, by Type, 2022 (%)
Ranitidine/Zantac
Cimetidine
Famotidine
Nazatidine
Global H2 Blockers Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global H2 Blockers Market Segment Percentages, by Application, 2022 (%)
Retail Stores
Clinics
Hospitals
OTC Sales
Global H2 Blockers Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global H2 Blockers Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies H2 Blockers revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies H2 Blockers revenues share in global market, 2022 (%)
Key companies H2 Blockers sales in global market, 2018-2023 (Estimated), (K Units)
Key companies H2 Blockers sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Acic Pharmaceuticals
Actavis Mid Atlantic LLC
Ajanta Pharma
AmerisourceBergen
Amneal Pharmaceuticals
ANDA Repository
Ani Pharmaceuticals
Apotex Inc. (and Apotex Corporation)
Appco Pharma
Aurobindo Pharma
Ben Venue Laboratories Inc.
Boehringer Ingelheim
Breckenridge Pharmaceuticals
Contract Pharmacal Corp.
Dr. Reddy’s Laboratories Inc.
Geri-Care Pharmaceuticals
GlaxoSmithKline
Glenmark Pharmaceuticals
Granules Pharmaceuticals Inc.
Heritage Pharma Labs Inc.
Hikma Pharmaceuticals
Hi-Tech Pharmacal Co.
Lannett Co.
Mylan Pharmaceuticals Inc.
Nostrum Laboratories Inc.
Novitium Pharma
PAI Holdings, LLC
Par Pharmaceutical Inc.
Perrigo
Ranbaxy Inc.
Sandoz Inc.
Sanofi-Aventis
Strides
Sun Pharma
Taro Pharmaceuticals
Teva Pharmaceuticals
Thirty Madison
Torrent Pharma
Unique Pharmaceutical Laboratories
VKT Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of H2 Blockers, market overview.
Chapter 2: Global H2 Blockers market size in revenue and volume.
Chapter 3: Detailed analysis of H2 Blockers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of H2 Blockers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global H2 Blockers capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 H2 Blockers Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global H2 Blockers Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global H2 Blockers Overall Market Size
2.1 Global H2 Blockers Market Size: 2022 VS 2029
2.2 Global H2 Blockers Revenue, Prospects & Forecasts: 2018-2029
2.3 Global H2 Blockers Sales: 2018-2029
3 Company Landscape
3.1 Top H2 Blockers Players in Global Market
3.2 Top Global H2 Blockers Companies Ranked by Revenue
3.3 Global H2 Blockers Revenue by Companies
3.4 Global H2 Blockers Sales by Companies
3.5 Global H2 Blockers Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 H2 Blockers Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers H2 Blockers Product Type
3.8 Tier 1, Tier 2 and Tier 3 H2 Blockers Players in Global Market
3.8.1 List of Global Tier 1 H2 Blockers Companies
3.8.2 List of Global Tier 2 and Tier 3 H2 Blockers Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global H2 Blockers Market Size Markets, 2022 & 2029
4.1.2 Ranitidine/Zantac
4.1.3 Cimetidine
4.1.4 Famotidine
4.1.5 Nazatidine
4.2 By Type – Global H2 Blockers Revenue & Forecasts
4.2.1 By Type – Global H2 Blockers Revenue, 2018-2023
4.2.2 By Type – Global H2 Blockers Revenue, 2024-2029
4.2.3 By Type – Global H2 Blockers Revenue Market Share, 2018-2029
4.3 By Type – Global H2 Blockers Sales & Forecasts
4.3.1 By Type – Global H2 Blockers Sales, 2018-2023
4.3.2 By Type – Global H2 Blockers Sales, 2024-2029
4.3.3 By Type – Global H2 Blockers Sales Market Share, 2018-2029
4.4 By Type – Global H2 Blockers Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global H2 Blockers Market Size, 2022 & 2029
5.1.2 Retail Stores
5.1.3 Clinics
5.1.4 Hospitals
5.1.5 OTC Sales
5.2 By Application – Global H2 Blockers Revenue & Forecasts
5.2.1 By Application – Global H2 Blockers Revenue, 2018-2023
5.2.2 By Application – Global H2 Blockers Revenue, 2024-2029
5.2.3 By Application – Global H2 Blockers Revenue Market Share, 2018-2029
5.3 By Application – Global H2 Blockers Sales & Forecasts
5.3.1 By Application – Global H2 Blockers Sales, 2018-2023
5.3.2 By Application – Global H2 Blockers Sales, 2024-2029
5.3.3 By Application – Global H2 Blockers Sales Market Share, 2018-2029
5.4 By Application – Global H2 Blockers Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global H2 Blockers Market Size, 2022 & 2029
6.2 By Region – Global H2 Blockers Revenue & Forecasts
6.2.1 By Region – Global H2 Blockers Revenue, 2018-2023
6.2.2 By Region – Global H2 Blockers Revenue, 2024-2029
6.2.3 By Region – Global H2 Blockers Revenue Market Share, 2018-2029
6.3 By Region – Global H2 Blockers Sales & Forecasts
6.3.1 By Region – Global H2 Blockers Sales, 2018-2023
6.3.2 By Region – Global H2 Blockers Sales, 2024-2029
6.3.3 By Region – Global H2 Blockers Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America H2 Blockers Revenue, 2018-2029
6.4.2 By Country – North America H2 Blockers Sales, 2018-2029
6.4.3 US H2 Blockers Market Size, 2018-2029
6.4.4 Canada H2 Blockers Market Size, 2018-2029
6.4.5 Mexico H2 Blockers Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe H2 Blockers Revenue, 2018-2029
6.5.2 By Country – Europe H2 Blockers Sales, 2018-2029
6.5.3 Germany H2 Blockers Market Size, 2018-2029
6.5.4 France H2 Blockers Market Size, 2018-2029
6.5.5 U.K. H2 Blockers Market Size, 2018-2029
6.5.6 Italy H2 Blockers Market Size, 2018-2029
6.5.7 Russia H2 Blockers Market Size, 2018-2029
6.5.8 Nordic Countries H2 Blockers Market Size, 2018-2029
6.5.9 Benelux H2 Blockers Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia H2 Blockers Revenue, 2018-2029
6.6.2 By Region – Asia H2 Blockers Sales, 2018-2029
6.6.3 China H2 Blockers Market Size, 2018-2029
6.6.4 Japan H2 Blockers Market Size, 2018-2029
6.6.5 South Korea H2 Blockers Market Size, 2018-2029
6.6.6 Southeast Asia H2 Blockers Market Size, 2018-2029
6.6.7 India H2 Blockers Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America H2 Blockers Revenue, 2018-2029
6.7.2 By Country – South America H2 Blockers Sales, 2018-2029
6.7.3 Brazil H2 Blockers Market Size, 2018-2029
6.7.4 Argentina H2 Blockers Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa H2 Blockers Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa H2 Blockers Sales, 2018-2029
6.8.3 Turkey H2 Blockers Market Size, 2018-2029
6.8.4 Israel H2 Blockers Market Size, 2018-2029
6.8.5 Saudi Arabia H2 Blockers Market Size, 2018-2029
6.8.6 UAE H2 Blockers Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Acic Pharmaceuticals
7.1.1 Acic Pharmaceuticals Company Summary
7.1.2 Acic Pharmaceuticals Business Overview
7.1.3 Acic Pharmaceuticals H2 Blockers Major Product Offerings
7.1.4 Acic Pharmaceuticals H2 Blockers Sales and Revenue in Global (2018-2023)
7.1.5 Acic Pharmaceuticals Key News & Latest Developments
7.2 Actavis Mid Atlantic LLC
7.2.1 Actavis Mid Atlantic LLC Company Summary
7.2.2 Actavis Mid Atlantic LLC Business Overview
7.2.3 Actavis Mid Atlantic LLC H2 Blockers Major Product Offerings
7.2.4 Actavis Mid Atlantic LLC H2 Blockers Sales and Revenue in Global (2018-2023)
7.2.5 Actavis Mid Atlantic LLC Key News & Latest Developments
7.3 Ajanta Pharma
7.3.1 Ajanta Pharma Company Summary
7.3.2 Ajanta Pharma Business Overview
7.3.3 Ajanta Pharma H2 Blockers Major Product Offerings
7.3.4 Ajanta Pharma H2 Blockers Sales and Revenue in Global (2018-2023)
7.3.5 Ajanta Pharma Key News & Latest Developments
7.4 AmerisourceBergen
7.4.1 AmerisourceBergen Company Summary
7.4.2 AmerisourceBergen Business Overview
7.4.3 AmerisourceBergen H2 Blockers Major Product Offerings
7.4.4 AmerisourceBergen H2 Blockers Sales and Revenue in Global (2018-2023)
7.4.5 AmerisourceBergen Key News & Latest Developments
7.5 Amneal Pharmaceuticals
7.5.1 Amneal Pharmaceuticals Company Summary
7.5.2 Amneal Pharmaceuticals Business Overview
7.5.3 Amneal Pharmaceuticals H2 Blockers Major Product Offerings
7.5.4 Amneal Pharmaceuticals H2 Blockers Sales and Revenue in Global (2018-2023)
7.5.5 Amneal Pharmaceuticals Key News & Latest Developments
7.6 ANDA Repository
7.6.1 ANDA Repository Company Summary
7.6.2 ANDA Repository Business Overview
7.6.3 ANDA Repository H2 Blockers Major Product Offerings
7.6.4 ANDA Repository H2 Blockers Sales and Revenue in Global (2018-2023)
7.6.5 ANDA Repository Key News & Latest Developments
7.7 Ani Pharmaceuticals
7.7.1 Ani Pharmaceuticals Company Summary
7.7.2 Ani Pharmaceuticals Business Overview
7.7.3 Ani Pharmaceuticals H2 Blockers Major Product Offerings
7.7.4 Ani Pharmaceuticals H2 Blockers Sales and Revenue in Global (2018-2023)
7.7.5 Ani Pharmaceuticals Key News & Latest Developments
7.8 Apotex Inc. (and Apotex Corporation)
7.8.1 Apotex Inc. (and Apotex Corporation) Company Summary
7.8.2 Apotex Inc. (and Apotex Corporation) Business Overview
7.8.3 Apotex Inc. (and Apotex Corporation) H2 Blockers Major Product Offerings
7.8.4 Apotex Inc. (and Apotex Corporation) H2 Blockers Sales and Revenue in Global (2018-2023)
7.8.5 Apotex Inc. (and Apotex Corporation) Key News & Latest Developments
7.9 Appco Pharma
7.9.1 Appco Pharma Company Summary
7.9.2 Appco Pharma Business Overview
7.9.3 Appco Pharma H2 Blockers Major Product Offerings
7.9.4 Appco Pharma H2 Blockers Sales and Revenue in Global (2018-2023)
7.9.5 Appco Pharma Key News & Latest Developments
7.10 Aurobindo Pharma
7.10.1 Aurobindo Pharma Company Summary
7.10.2 Aurobindo Pharma Business Overview
7.10.3 Aurobindo Pharma H2 Blockers Major Product Offerings
7.10.4 Aurobindo Pharma H2 Blockers Sales and Revenue in Global (2018-2023)
7.10.5 Aurobindo Pharma Key News & Latest Developments
7.11 Ben Venue Laboratories Inc.
7.11.1 Ben Venue Laboratories Inc. Company Summary
7.11.2 Ben Venue Laboratories Inc. H2 Blockers Business Overview
7.11.3 Ben Venue Laboratories Inc. H2 Blockers Major Product Offerings
7.11.4 Ben Venue Laboratories Inc. H2 Blockers Sales and Revenue in Global (2018-2023)
7.11.5 Ben Venue Laboratories Inc. Key News & Latest Developments
7.12 Boehringer Ingelheim
7.12.1 Boehringer Ingelheim Company Summary
7.12.2 Boehringer Ingelheim H2 Blockers Business Overview
7.12.3 Boehringer Ingelheim H2 Blockers Major Product Offerings
7.12.4 Boehringer Ingelheim H2 Blockers Sales and Revenue in Global (2018-2023)
7.12.5 Boehringer Ingelheim Key News & Latest Developments
7.13 Breckenridge Pharmaceuticals
7.13.1 Breckenridge Pharmaceuticals Company Summary
7.13.2 Breckenridge Pharmaceuticals H2 Blockers Business Overview
7.13.3 Breckenridge Pharmaceuticals H2 Blockers Major Product Offerings
7.13.4 Breckenridge Pharmaceuticals H2 Blockers Sales and Revenue in Global (2018-2023)
7.13.5 Breckenridge Pharmaceuticals Key News & Latest Developments
7.14 Contract Pharmacal Corp.
7.14.1 Contract Pharmacal Corp. Company Summary
7.14.2 Contract Pharmacal Corp. Business Overview
7.14.3 Contract Pharmacal Corp. H2 Blockers Major Product Offerings
7.14.4 Contract Pharmacal Corp. H2 Blockers Sales and Revenue in Global (2018-2023)
7.14.5 Contract Pharmacal Corp. Key News & Latest Developments
7.15 Dr. Reddy’s Laboratories Inc.
7.15.1 Dr. Reddy’s Laboratories Inc. Company Summary
7.15.2 Dr. Reddy’s Laboratories Inc. Business Overview
7.15.3 Dr. Reddy’s Laboratories Inc. H2 Blockers Major Product Offerings
7.15.4 Dr. Reddy’s Laboratories Inc. H2 Blockers Sales and Revenue in Global (2018-2023)
7.15.5 Dr. Reddy’s Laboratories Inc. Key News & Latest Developments
7.16 Geri-Care Pharmaceuticals
7.16.1 Geri-Care Pharmaceuticals Company Summary
7.16.2 Geri-Care Pharmaceuticals Business Overview
7.16.3 Geri-Care Pharmaceuticals H2 Blockers Major Product Offerings
7.16.4 Geri-Care Pharmaceuticals H2 Blockers Sales and Revenue in Global (2018-2023)
7.16.5 Geri-Care Pharmaceuticals Key News & Latest Developments
7.17 GlaxoSmithKline
7.17.1 GlaxoSmithKline Company Summary
7.17.2 GlaxoSmithKline Business Overview
7.17.3 GlaxoSmithKline H2 Blockers Major Product Offerings
7.17.4 GlaxoSmithKline H2 Blockers Sales and Revenue in Global (2018-2023)
7.17.5 GlaxoSmithKline Key News & Latest Developments
7.18 Glenmark Pharmaceuticals
7.18.1 Glenmark Pharmaceuticals Company Summary
7.18.2 Glenmark Pharmaceuticals Business Overview
7.18.3 Glenmark Pharmaceuticals H2 Blockers Major Product Offerings
7.18.4 Glenmark Pharmaceuticals H2 Blockers Sales and Revenue in Global (2018-2023)
7.18.5 Glenmark Pharmaceuticals Key News & Latest Developments
7.19 Granules Pharmaceuticals Inc.
7.19.1 Granules Pharmaceuticals Inc. Company Summary
7.19.2 Granules Pharmaceuticals Inc. Business Overview
7.19.3 Granules Pharmaceuticals Inc. H2 Blockers Major Product Offerings
7.19.4 Granules Pharmaceuticals Inc. H2 Blockers Sales and Revenue in Global (2018-2023)
7.19.5 Granules Pharmaceuticals Inc. Key News & Latest Developments
7.20 Heritage Pharma Labs Inc.
7.20.1 Heritage Pharma Labs Inc. Company Summary
7.20.2 Heritage Pharma Labs Inc. Business Overview
7.20.3 Heritage Pharma Labs Inc. H2 Blockers Major Product Offerings
7.20.4 Heritage Pharma Labs Inc. H2 Blockers Sales and Revenue in Global (2018-2023)
7.20.5 Heritage Pharma Labs Inc. Key News & Latest Developments
7.21 Hikma Pharmaceuticals
7.21.1 Hikma Pharmaceuticals Company Summary
7.21.2 Hikma Pharmaceuticals Business Overview
7.21.3 Hikma Pharmaceuticals H2 Blockers Major Product Offerings
7.21.4 Hikma Pharmaceuticals H2 Blockers Sales and Revenue in Global (2018-2023)
7.21.5 Hikma Pharmaceuticals Key News & Latest Developments
7.22 Hi-Tech Pharmacal Co.
7.22.1 Hi-Tech Pharmacal Co. Company Summary
7.22.2 Hi-Tech Pharmacal Co. Business Overview
7.22.3 Hi-Tech Pharmacal Co. H2 Blockers Major Product Offerings
7.22.4 Hi-Tech Pharmacal Co. H2 Blockers Sales and Revenue in Global (2018-2023)
7.22.5 Hi-Tech Pharmacal Co. Key News & Latest Developments
7.23 Lannett Co.
7.23.1 Lannett Co. Company Summary
7.23.2 Lannett Co. Business Overview
7.23.3 Lannett Co. H2 Blockers Major Product Offerings
7.23.4 Lannett Co. H2 Blockers Sales and Revenue in Global (2018-2023)
7.23.5 Lannett Co. Key News & Latest Developments
7.24 Mylan Pharmaceuticals Inc.
7.24.1 Mylan Pharmaceuticals Inc. Company Summary
7.24.2 Mylan Pharmaceuticals Inc. Business Overview
7.24.3 Mylan Pharmaceuticals Inc. H2 Blockers Major Product Offerings
7.24.4 Mylan Pharmaceuticals Inc. H2 Blockers Sales and Revenue in Global (2018-2023)
7.24.5 Mylan Pharmaceuticals Inc. Key News & Latest Developments
7.25 Nostrum Laboratories Inc.
7.25.1 Nostrum Laboratories Inc. Company Summary
7.25.2 Nostrum Laboratories Inc. Business Overview
7.25.3 Nostrum Laboratories Inc. H2 Blockers Major Product Offerings
7.25.4 Nostrum Laboratories Inc. H2 Blockers Sales and Revenue in Global (2018-2023)
7.25.5 Nostrum Laboratories Inc. Key News & Latest Developments
7.26 Novitium Pharma
7.26.1 Novitium Pharma Company Summary
7.26.2 Novitium Pharma Business Overview
7.26.3 Novitium Pharma H2 Blockers Major Product Offerings
7.26.4 Novitium Pharma H2 Blockers Sales and Revenue in Global (2018-2023)
7.26.5 Novitium Pharma Key News & Latest Developments
7.27 PAI Holdings, LLC
7.27.1 PAI Holdings, LLC Company Summary
7.27.2 PAI Holdings, LLC Business Overview
7.27.3 PAI Holdings, LLC H2 Blockers Major Product Offerings
7.27.4 PAI Holdings, LLC H2 Blockers Sales and Revenue in Global (2018-2023)
7.27.5 PAI Holdings, LLC Key News & Latest Developments
7.28 Par Pharmaceutical Inc.
7.28.1 Par Pharmaceutical Inc. Company Summary
7.28.2 Par Pharmaceutical Inc. Business Overview
7.28.3 Par Pharmaceutical Inc. H2 Blockers Major Product Offerings
7.28.4 Par Pharmaceutical Inc. H2 Blockers Sales and Revenue in Global (2018-2023)
7.28.5 Par Pharmaceutical Inc. Key News & Latest Developments
7.29 Perrigo
7.29.1 Perrigo Company Summary
7.29.2 Perrigo Business Overview
7.29.3 Perrigo H2 Blockers Major Product Offerings
7.29.4 Perrigo H2 Blockers Sales and Revenue in Global (2018-2023)
7.29.5 Perrigo Key News & Latest Developments
7.30 Ranbaxy Inc.
7.30.1 Ranbaxy Inc. Company Summary
7.30.2 Ranbaxy Inc. Business Overview
7.30.3 Ranbaxy Inc. H2 Blockers Major Product Offerings
7.30.4 Ranbaxy Inc. H2 Blockers Sales and Revenue in Global (2018-2023)
7.30.5 Ranbaxy Inc. Key News & Latest Developments
7.31 Sandoz Inc.
7.31.1 Sandoz Inc. Company Summary
7.31.2 Sandoz Inc. Business Overview
7.31.3 Sandoz Inc. H2 Blockers Major Product Offerings
7.31.4 Sandoz Inc. H2 Blockers Sales and Revenue in Global (2018-2023)
7.31.5 Sandoz Inc. Key News & Latest Developments
7.32 Sanofi-Aventis
7.32.1 Sanofi-Aventis Company Summary
7.32.2 Sanofi-Aventis Business Overview
7.32.3 Sanofi-Aventis H2 Blockers Major Product Offerings
7.32.4 Sanofi-Aventis H2 Blockers Sales and Revenue in Global (2018-2023)
7.32.5 Sanofi-Aventis Key News & Latest Developments
7.33 Strides
7.33.1 Strides Company Summary
7.33.2 Strides Business Overview
7.33.3 Strides H2 Blockers Major Product Offerings
7.33.4 Strides H2 Blockers Sales and Revenue in Global (2018-2023)
7.33.5 Strides Key News & Latest Developments
7.34 Sun Pharma
7.34.1 Sun Pharma Company Summary
7.34.2 Sun Pharma Business Overview
7.34.3 Sun Pharma H2 Blockers Major Product Offerings
7.34.4 Sun Pharma H2 Blockers Sales and Revenue in Global (2018-2023)
7.34.5 Sun Pharma Key News & Latest Developments
7.35 Taro Pharmaceuticals
7.35.1 Taro Pharmaceuticals Company Summary
7.35.2 Taro Pharmaceuticals Business Overview
7.35.3 Taro Pharmaceuticals H2 Blockers Major Product Offerings
7.35.4 Taro Pharmaceuticals H2 Blockers Sales and Revenue in Global (2018-2023)
7.35.5 Taro Pharmaceuticals Key News & Latest Developments
7.36 Teva Pharmaceuticals
7.36.1 Teva Pharmaceuticals Company Summary
7.36.2 Teva Pharmaceuticals Business Overview
7.36.3 Teva Pharmaceuticals H2 Blockers Major Product Offerings
7.36.4 Teva Pharmaceuticals H2 Blockers Sales and Revenue in Global (2018-2023)
7.36.5 Teva Pharmaceuticals Key News & Latest Developments
7.37 Thirty Madison
7.37.1 Thirty Madison Company Summary
7.37.2 Thirty Madison Business Overview
7.37.3 Thirty Madison H2 Blockers Major Product Offerings
7.37.4 Thirty Madison H2 Blockers Sales and Revenue in Global (2018-2023)
7.37.5 Thirty Madison Key News & Latest Developments
7.38 Torrent Pharma
7.38.1 Torrent Pharma Company Summary
7.38.2 Torrent Pharma Business Overview
7.38.3 Torrent Pharma H2 Blockers Major Product Offerings
7.38.4 Torrent Pharma H2 Blockers Sales and Revenue in Global (2018-2023)
7.38.5 Torrent Pharma Key News & Latest Developments
7.39 Unique Pharmaceutical Laboratories
7.39.1 Unique Pharmaceutical Laboratories Company Summary
7.39.2 Unique Pharmaceutical Laboratories Business Overview
7.39.3 Unique Pharmaceutical Laboratories H2 Blockers Major Product Offerings
7.39.4 Unique Pharmaceutical Laboratories H2 Blockers Sales and Revenue in Global (2018-2023)
7.39.5 Unique Pharmaceutical Laboratories Key News & Latest Developments
7.40 VKT Pharma
7.40.1 VKT Pharma Company Summary
7.40.2 VKT Pharma Business Overview
7.40.3 VKT Pharma H2 Blockers Major Product Offerings
7.40.4 VKT Pharma H2 Blockers Sales and Revenue in Global (2018-2023)
7.40.5 VKT Pharma Key News & Latest Developments
8 Global H2 Blockers Production Capacity, Analysis
8.1 Global H2 Blockers Production Capacity, 2018-2029
8.2 H2 Blockers Production Capacity of Key Manufacturers in Global Market
8.3 Global H2 Blockers Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 H2 Blockers Supply Chain Analysis
10.1 H2 Blockers Industry Value Chain
10.2 H2 Blockers Upstream Market
10.3 H2 Blockers Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 H2 Blockers Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



★調査レポート[世界のH2ブロッカー市場予測2023-2029：ラニチジン/ザンタック、シメチジン、ファモチジン、ナザチジン] (コード：MMG23JU5600)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のH2ブロッカー市場予測2023-2029：ラニチジン/ザンタック、シメチジン、ファモチジン、ナザチジン]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のエストロゲンブロッカー市場予測2023-2029：チロキシン促進剤、コルチゾール阻害剤、アロマターゼ阻害剤
  • 世界の小児用ADHD治療薬市場予測2023-2029：錠剤、経口液、その他
  • 世界のオピエートきっ抗剤市場予測2023-2029：0.4mg/ml、1mg/ml、2mg/ml
  • 世界の散瞳薬市場予測2023-2029：0.01、0.02、0.1、その他
  • 世界のアスパラギナーゼ市場予測2023-2029：大腸菌、Erwinia chrysanthemi、ペグ化
  • 世界の痔疾患用鎮痛剤市場予測2023-2029：チューブ、クリーム
  • 世界のエナント酸メテノロン市場予測2023-2029：経口、注射
  • 世界のアポモルヒネ塩酸塩注射液市場予測2023-2029：ペン型注射器、輸液ポンプ
  • 世界の骨吸収阻害剤市場予測2023-2029：経口式、非経口式
  • 世界の筋強直性ジストロフィー治療薬市場予測2023-2029：ナトリウムチャネル遮断薬、三環系抗うつ薬、その他

    • ◆H&Iグローバルリサーチのお客様（例）◆